The Irish Times

Malin eyes more investments and returning cash in 2022

Litigation-related costs came to €400,000 last year as founders sue for direct stake

Tue Mar 15 2022 - 08:10

Apple soared and Zoom slumped in a year that saw markets surge to record levels

Fri Dec 31 2021 - 05:20

Uniphar’s gross profit surges 31% in the first half of the year

Wed Dec 29 2021 - 17:20

Irish biopharmaceutical company stake part of package sold to Rosetta Capital

Fri Apr 09 2021 - 17:07

ISIF owns almost 11% of Malin, which saw the value of its portfolio jump since late 2019

Tue Mar 23 2021 - 17:48

Cantillon: Davy says Malin shareholders can expect to see payout of close to €50m based on Monday’s share price

Tue Jan 12 2021 - 05:56

Irish life sciences company holds 10% stake in immunotherapy firm

Mon Jan 11 2021 - 09:53

Troubled asset manager thought to have sold 1.6m shares earlier this week

Thu Oct 03 2019 - 19:33

Biopharmaceutical company Kymab identified as one of Malin’s four ‘core assets’

Mon May 13 2019 - 16:17

Former Ardagh CEO Ian Curley to become executive chairman on an interim basis

Fri Oct 12 2018 - 10:53